Morten Baltzer Houlind is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, specializing in translational and clinical pharmacology. His work focuses on optimizing drug therapy for elderly patients through advanced renal function assessment and biomarker development. Dr. Houlind's research centers on geriatric pharmacology with emphasis on glomerular filtration rate (GFR) measurement techniques, biomarker validation (suPAR, NGAL, KIM-1, GDF-15), and cannabinoid pharmacokinetics in aging populations. His projects include developing dried blood spot testing protocols, improving medication review systems for acute hospital admissions, and conducting clinical trials on appetite stimulation therapies for elderly patients with poor appetite. Analysis of his recent publications reveals a cohesive research trajectory focused on precision dosing in geriatric care, integrating pharmacokinetic modeling with novel biomarker discovery to address renal impairment challenges. His work consistently targets practical clinical applications for vulnerable elderly populations, particularly in hospital settings where polypharmacy and renal dysfunction complicate treatment.
Mikkel Rathsach Andersen serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen, Denmark, with specialized clinical duties in Orthopaedic Surgery at the Capital Region of Denmark (Region Hovedstaden). His work is anchored at the Center for Fast-track Hip and Knee Replacement, where he contributes to pioneering accelerated surgical pathways for joint arthroplasty across multiple hospital sites including Herlev Hospital (Borgmester Ib Juuls Vej 1, 2730 Herlev) and Rigshospitalet (Blegdamsvej 3, 2200 København N.). Andersen's research program centers on optimizing perioperative care for hip and knee arthroplasty patients, with particular focus on enabling day-case and outpatient surgery in public healthcare systems. His investigations span comorbidity management (non-anaemic iron deficiency, diabetes), pain control protocols, and predictive modeling for surgical outcomes. He examines how interventions like perioperative steroids, nerve blocks, and tailored anaemia management influence length of stay, readmission rates, and functional recovery, directly informing evidence-based fast-track protocols that balance efficiency with patient safety. Analysis of his 2023-2025 publications reveals a cohesive research trajectory focused on fast-track arthroplasty implementation. His work consistently addresses barriers to same-day discharge through prospective multicenter designs, demonstrating that day-case protocols do not increase healthcare utilization while identifying modifiable risk factors like iron deficiency. Notably, his comparative study on machine learning versus logistic regression for morbidity prediction highlights growing integration of data science in perioperative decision-making, though clinical adoption remains cautious. Andersen operates within the internationally recognized Center for Fast-track Hip and Knee Replacement, a collaborative hub that integrates clinical practice, research, and education. His frequent co-authorship with perioperative medicine pioneers like Henrik Kehlet and Søren Overgaard demonstrates embeddedness in a robust research network, with publications generating significant Scopus citations and Mendeley readership. This work directly impacts public healthcare policy through evidence-based implementation of outpatient arthroplasty pathways across Denmark's public hospital system.
Niels Klarskov is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen, specializing in Obstetrics and Gynaecology. Based at Borgmester Ib Juuls Vej 1, Herlev and Blegdamsvej 3, Copenhagen, his work bridges clinical practice and academic research in pelvic health disorders. His research focuses on urogynecological conditions , particularly urinary and fecal incontinence management. Key interests include neuromodulation therapies, Botox applications for overactive bladder, pelvic floor biomechanics, and evidence-based treatment comparisons. His work emphasizes clinical trial methodologies, diagnostic innovations, and therapeutic outcome prediction. Klarskov's recent publications (2024-2025) demonstrate a consistent focus on pelvic floor dysfunction and incontinence treatments , with emphases on Botox efficacy, sphincter function analysis, surgical outcomes, and diagnostic model validation. The research employs diverse methodologies including RCTs, cohort studies, and observational analyses.
Petar Vladimirov Todorov is a Researcher at the Center for Basic Metabolic Research (CBMR) within the Faculty of Health and Medical Sciences at the University of Copenhagen. His work focuses on genetic and genomic mechanisms underlying metabolic disorders, with primary affiliations to the Pers Group and CBMR located at Blegdamsvej 3B, Mærsk Tårnet. His research spans Genetics, Genomics, Metabolism, Obesity, Diabetes, and Neuroscience. He employs RNA-seq, GWAS, and single-cell mapping techniques to investigate brain areas in fasting/diet-induced obesity, glucose metabolism, and dietary intake patterns. His interdisciplinary approach bridges molecular mechanisms with metabolic phenotypes, particularly in neural regulation of metabolism. His 2021-2024 publications reveal consistent focus on metabolic neuroscience and large-scale genomics, with articles in Scientific Data, Nature Genetics, Nature Human Behaviour, and Diabetes. These works demonstrate expertise in translating genomic data into insights about obesity, diabetes pathophysiology, and neural control of metabolism, with significant media attention including coverage by 14 news outlets. No scientific awards were mentioned in the source material. No information regarding student advising or research grants was provided in the scraped text. He operates within the Pers Group at the Center for Basic Metabolic Research (CBMR), leveraging institutional resources at the University of Copenhagen's Faculty of Health and Medical Sciences for cutting-edge metabolic research.
Per Waaben Hansen serves as an Adjunct Professor in the Department of Food Science at the University of Copenhagen, specifically affiliated with the Ingredient and Dairy Technology section. His academic role centers on advancing scientific understanding of food components within dairy systems, leveraging institutional resources at Rolighedsvej 26 in Frederiksberg C. His research program fundamentally addresses Food Science through the specialized lenses of Dairy Technology and Lipid Science, with particular emphasis on computational approaches to model fatty acid behavior. This work bridges Food Chemistry and Ingredient Technology to solve industry challenges in dairy product development, while Food Modeling techniques enable predictive analysis of ingredient interactions. His scholarly focus reflects contemporary demands for precision in food composition science and sustainable dairy innovation. Analysis of his publication output reveals a concentrated research trajectory in fatty acid modeling, demonstrating interdisciplinary integration of dairy chemistry, nutritional science, and data-driven methodologies. This singular focus on global compositional models indicates strategic specialization rather than broad diversification, targeting applications in dairy quality control and ingredient optimization within international food systems. No scientific awards, student mentoring records, grant funding details, or laboratory team structures were documented in the source materials, reflecting either omission in the scraped content or absence of such activities in his current academic profile.
Julie Aamand Olesen is a Researcher at the Research Unit for General Practice (Forskningsenheden for Almen Praksis) within the Center for Health and Society (Center for Sundhed og Samfund) at the University of Copenhagen. Her work focuses on optimizing clinical decision-making in primary care, particularly regarding antibiotic prescribing for urinary tract infections in nursing homes and addressing overdiagnosis in infectious diseases. Her academic credentials include a BSc in Medicine from Aarhus University and a Master's in Public Health (Cand.scient.san.publ.) from the University of Copenhagen. Dr. Olesen's research spans General Practice, Antibiotic Stewardship, and Schizophrenia comorbidity studies. She employs mixed-methods approaches including Normalization Process Theory frameworks and clinical data analysis to investigate diagnostic accuracy, intervention implementation, and substance-use interactions with physical health. Her work emphasizes reducing unnecessary antibiotic use through system-level changes in nursing home care. Analysis of her 2018-2022 publications reveals consistent focus on urinary tract infection management in vulnerable elderly populations, with increasing methodological sophistication in intervention design. A secondary research strand examines paradoxical protective effects of cannabis use disorders in schizophrenia-related gastrointestinal conditions. Her findings have influenced policy discussions on antimicrobial resistance and been disseminated through high-impact journals like BMC Geriatrics and Antibiotics . She operates within the Research Unit for General Practice, collaborating with interdisciplinary teams across the University of Copenhagen's health sciences division to translate research into clinical practice improvements for nursing home residents and primary care settings.
Anders Møller Greve serves as a Guest researcher at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, specializing in the Renal and Vascular Research group. His work bridges clinical cardiology, nephrology, and transplantation medicine through large-scale Danish registry studies and translational projects. Greve’s research focuses on cardiorenal interactions, vascular diagnostics, and post-transplant outcomes. Key areas include risk stratification for aortic stenosis (ASGARD score development), glomerular filtration rate measurement standardization, and mechanisms linking kidney disease to cardiac conduction disorders. His methodology emphasizes real-world evidence from nationwide cohorts and advanced imaging techniques like SPECT. Analysis of his 2024-2025 publications reveals a cohesive trajectory toward integrated cardiorenal risk prediction. Studies consistently leverage Denmark’s comprehensive health registries to investigate mortality predictors (e.g., transthyretin destabilization), procedural outcomes (e.g., left atrial appendage closure), and diagnostic innovations in pulmonary hypertension and lung transplantation. Scientific awards: No awards were documented in the source material. Advising and grants: No information regarding student supervision, research grants, or funded projects was provided. He operates within the Renal and Vascular Research unit at Københavns Universitet, which utilizes population-based data and clinical cohorts to explore vascular pathophysiology, renal-cardiac cross-talk, and therapeutic interventions in chronic disease management.
Jørgen Olsen is a Professor at the Department of Cellular and Molecular Medicine, University of Copenhagen, specializing in the Morphogenesis and Differentiation Program within the Faculty of Health and Medical Sciences. His research focuses on gastrointestinal mucosa development and inflammatory bowel diseases, with significant contributions to translational medicine including the discovery of rectal insulin as a potential treatment for colitis. Dr. Olsen received his Medical Doctor degree from the University of Copenhagen in 1992 and his Doctor Medicinae (DMSc) from the Faculty of Health Sciences at the same institution in 1998. His academic journey progressed from research assistant to professor, with appointments at the Department of Medical Biochemistry & Genetics and later the Department of Cellular & Molecular Medicine. His primary research interests center on morphogenesis and differentiation of the gastrointestinal mucosa, with special focus on bioinformatics interpretation of alterations in molecular profiles (transcriptome, metabolome) during mucosal inflammation. His laboratory uses mouse models for intestinal inflammation which are translated into applied research for inflammatory bowel diseases. A significant recent discovery involves the use of rectal insulin as treatment for inflammatory bowel disease, where his team demonstrated that colitis in mice can be treated using rectal instillation of insulin. Analysis of his recent publications reveals a strong focus on medical education during the pandemic era, particularly regarding student perspectives on death, body donation, and professional identity formation. His earlier work shows consistent expertise in gastrointestinal biology, molecular mechanisms of inflammation, and bioinformatics approaches to understanding mucosal disorders. The research spans basic science through clinical translation, with increasing international collaboration in recent years. Dr. Olsen has served as supervisor for 7 PhD students, 12 masters students, and 2 scholar stipend students, and has participated in evaluation committees for numerous academic positions and theses. His teaching innovations include "The Modern Anatomical Theater," "Q+A livestreamed sessions," and digital learning resources. His research has been supported by multiple grants from the Novo Nordisk Foundation, Danish Medical Research Council, and other organizations, totaling over 4 million DKK in awarded funding. He is also CEO and co-founder of Enterotarget ApS, which holds a license agreement with the University of Copenhagen for the patent "Rectal insulin for treatment of inflammatory bowel disease" (EP3538132A1).
Stefan Stender serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, with institutional affiliation through the Capital Region of Denmark (Region Hovedstaden). His research bridges clinical medicine and genomic science, focusing on translational applications in hepatology and cardiology. Dr. Stender's primary research interests center on genetic determinants of liver diseases—including hepatocellular carcinoma, cirrhosis, and metabolic dysfunction-associated steatotic liver disease (MetALD)—and cardiovascular risk mechanisms involving lipoprotein(a) and polygenic risk scores. His work integrates large-scale genomic analyses with clinical outcomes to develop risk prediction models, emphasizing the translation of genetic discoveries into clinical practice for cardiovascular and liver conditions. Analysis of his 2024-2025 publications reveals a strong trend toward collaborative, high-impact genomic research, particularly through consortia like DBDS Genomic Consortium. His work spans hepatology (focusing on genetic architecture of liver cirrhosis and hepatocellular carcinoma) and cardiology (examining lipoprotein(a) stability and polygenic risk implementation), consistently targeting clinical applications of genetic findings in major journals such as Nature Genetics and European Heart Journal .
Charlotte O'Shea is an Academic employee at the Department of Biology, Biomolecular Sciences, University of Copenhagen. Her research focuses on molecular mechanisms in plant stress responses, protein structure and function, and computational approaches to protein design. Based at Ole Maaløes Vej 5 in Copenhagen, she maintains an active research program with numerous publications spanning biochemistry, molecular biology, and plant sciences. Her primary research interests include: Transcription factor regulation and protein-protein interactions in plants Mechanisms of plant stress responses to environmental challenges Protein folding, stability, and conformational dynamics Computational methods for protein design and engineering Molecular mechanisms of gene regulation through alternative splicing Dr. O'Shea's publication record demonstrates a strong interdisciplinary approach combining biochemical, biophysical, and computational methodologies. Her recent work has appeared in high-impact journals including Nature Communications, Nucleic Acids Research, and Journal of the American Chemical Society, with several papers receiving significant citations and attention in the scientific community. Her research trajectory shows consistent productivity with publications spanning from 2021 to the current year of 2025. Her scientific contributions have garnered attention across academic platforms, with multiple publications shared by X users and tracked by readers on Mendeley, indicating engagement with the broader research community. While specific awards are not documented in the provided information, the quality and impact of her work are evident through citations and continued publication in reputable journals.
Niels Cramer West serves as a Clinical Associate Professor within the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His institutional base is located at Blegdamsvej 3, 2200 Copenhagen N, Denmark, aligned with the Capital Region healthcare system. His research centers on integrating artificial intelligence into anaesthesia practice through the TRIPLE-A (The AI and Automation in Anaesthesia) Perioperative Database initiative. Key interests include developing AI-driven prediction models for perioperative outcomes, implementing automated data retrieval systems, and establishing quality control frameworks in clinical anaesthesia. This work bridges clinical medicine with data science to enhance patient safety and procedural efficiency. As a core member of the TRIPLE-A Collaborator Group, West contributes to a multi-institutional platform spanning Eastern Denmark that enables epidemiological research and real-time clinical analytics. The group's 2025 publication in Acta Anaesthesiologica Scandinavica demonstrates their focus on transforming perioperative data into actionable clinical intelligence through advanced computational methods.
Cilius Esmann Fonvig serves as Clinical Associate Professor at the Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen. His clinical affiliation extends to Region Sjælland (email domain regionsjaelland.dk), reflecting Denmark's integrated university-hospital academic model. Based at Holbæk Hospital (Smedelundsgade 60) with Copenhagen campus connections (Blegdamsvej 3), he maintains active research in pediatric metabolic disorders. His research centers on childhood obesity and cardiometabolic risk, with specific expertise in genetic and proteomic determinants of metabolic health. Key focus areas include: Genetic risk scoring for insulin resistance in pediatric populations Plasma proteome and lipidome profiling in obesity Gut microbiome interactions with metabolic disease Non-pharmacological obesity intervention outcomes Age-dependent biomarker discovery Recent publications in Cell , Nature Medicine , and Nature Genetics demonstrate high-impact contributions to understanding obesity-related metabolic pathways in children. Analysis of his 44 research outputs (2025) reveals strong collaboration networks with leading Danish researchers including Torben Hansen, Jens-Christian Holm, and Signe Stellingwerff. His work frequently appears in high-visibility journals with significant media coverage (13 news outlets for key studies) and substantial academic engagement (128+ Mendeley readers per major paper). The research consistently addresses clinically actionable biomarkers and intervention strategies for childhood metabolic disorders. Fonvig participates in major consortia including GALAXY and MicrobLiver, indicating leadership in large-scale collaborative projects. His work demonstrates translational impact through policy citations (e.g., Childhood Obesity journal paper) and clinical application of findings in Danish obesity management programs.
Claus Børsting is a Senior Researcher at the Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He has been with the institution since 2001, holding various positions including Forensic Geneticist, Assistant Professor, and Senior Advisor before becoming a Senior Researcher in 2018. Dr. Børsting's educational background includes: 1984-1986: Gymnasium education (mathematics and physics) 1986-1987: Military service February 1994: Cand. Scient (Institute of Molecular Biology, University of Odense) November 1998-April 2000: Postdoctoral position at Albany Medical Center, New York, USA April 1999: Ph.D. (Institute of Molecular Biology, University of Odense) Dr. Børsting specializes in forensic genetics with primary research interests in: Identification of humans by bi-allelic markers Pigmentation of humans Use of next generation sequencing in forensic genetics Epigenetics His current research focuses on identification of humans by SNP typing and human pigmentation. Dr. Børsting has been instrumental in exploring the use of next generation sequencing (NGS) methods in forensic genetics, particularly with Ion torrent (ThermoFisher) and MiSeq (Illumina) platforms. His work has evolved from early contributions to the EU-sponsored SNP for ID consortium (2002-2006) to current research on microhaplotypes, epigenetic age estimation, and forensic investigative genetic genealogy. Dr. Børsting has received recognition for his extensive publication record: 79 peer-reviewed articles 12 book chapters 40 peer-reviewed conference proceedings 52 other conference contributions (poster or oral) Since 2012, Dr. Børsting has primarily focused on co-supervising Bachelor, Master, and PhD students, while also managing the research group at the Section of Forensic Genetics. He has been actively involved in peer review for journals including Forensic Science International: Genetics, International Journal of Legal Medicine, and Journal of Forensic Science and Medicine.
Leonardo Victor de Knegt serves as an Associate Professor in the Department of Veterinary and Animal Sciences at the Faculty of Health and Medical Sciences, University of Copenhagen. His research centers on animal welfare and disease control within livestock production systems, with particular expertise in swine nutrition, gastrointestinal health, and veterinary epidemiology. Dr. de Knegt's research program investigates critical challenges in modern livestock farming, including optimizing piglet development through dietary interventions (e.g., benzoic acid and lactose supplementation), mitigating stress in gestating sows, and enhancing disease surveillance in cattle populations. His work integrates molecular biology, nutritional science, and advanced statistical modeling to address complex interactions between feed composition, animal physiology, and production outcomes. Key methodologies include gene expression analysis, state space modeling for dairy herd management, and genomic contact-tracing for infectious disease control. Analysis of his 2020-2025 publications reveals a cohesive research trajectory focused on improving animal health through nutritional innovation and precision monitoring. Dominant themes include feed additive efficacy in neonatal piglets, risk factor identification for reproductive challenges in hyperprolific sows, and computational approaches to dairy farm management. His collaborative network spans multiple University of Copenhagen departments and international research teams, consistently targeting practical solutions for sustainable livestock production. Dr. de Knegt maintains an active publication record with 34 research outputs including 22 peer-reviewed journal articles. His work appears in high-impact journals such as Animals , Journal of Dairy Science , and Preventive Veterinary Medicine , demonstrating significant contributions to veterinary science methodology and livestock welfare applications.
Oliver James Hulme serves as Associate Professor in the Department of Psychology within the Faculty of Social Sciences at the University of Copenhagen. His office is located at Øster Farimagsgade 2A, 1350 København K, with scheduled office hours on Thursdays from 12:00-13:00. His research focuses on: Reward decision-making risk-taking neuroeconomics functional neuroimaging Bayesian modelling cognitive computational neuroscience open science Publications from 2013-2024 demonstrate sustained investigation into neural mechanisms of decision processes, particularly in Parkinson's disease, aging populations, and eating disorders. His methodology integrates fMRI, computational modeling, and behavioral paradigms to examine risk assessment, neural connectivity, and cognitive control under varying physiological states. No scientific awards were documented in the source material. Details regarding student supervision, grant funding, and laboratory infrastructure were not provided in the available information.
